NextCell Pharma Ab: Clinical Trials

3 trials sponsored by NextCell Pharma Ab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting. 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Active not recruiting 1
Phase 22Completed 2

Follow NextCell Pharma Ab: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans®
ProTrans® - COVID-19 Acute Respiratory Distress Syndrome, Influenza A
Phase 1Active not recruitingNextCell Pharma Ab92021-05-182025-05-14
Wharton´s Jelly Derived Mesenchymal Stromal Cell Repeated Treatment of Adult Patients Diagnosed with Type I Diabetes
ProTrans, Control - Type1diabetes
Phase 1 / Phase 2CompletedNextCell Pharma Ab152019-05-172025-03-07
Wharton´s Jelly Derived Mesenchymal Stromal Cell Treatment of Adult Patients Diagnosed With Type I Diabetes
ProTrans: Allogeneic transplantation with WJMSCs, Placebos - Type1 Diabetes Mellitus
Phase 1 / Phase 2CompletedNextCell Pharma Ab242017-11-282023-04-03

Conditions studied

Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 1 (1)

Interventions

Transplantation, Homologous (1)

Countries

Sweden (3)

Top investigators

Josefine Sundh, MD (1)  ·  Mathias Svahn, PhD (1)  ·  Per-Ola Carlsson, MD, PhD (1)  ·  Per-Ola Carlsson, PhD (1)

Results publications

PMID 37221247

NIH funding

2017 (1), 2018 (1)